Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
Journal of Autism and Developmental Disorders
|
April 13, 2024
Applicability and Psychometric Properties of General Mental Health Assessment Tools in Autistic People: A Systematic Review
Marianne Berg Halvorsen, Arvid Nikolai Kildahl, Sabine Kaiser, et al.
Research in Developmental Disabilities
|
September 5, 2008
Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children
Michael G Aman, Jill A Hollway, Sarah Leone, et al.
Biological Psychiatry
|
January 11, 2007
Risperidone and cognitive function in children with disruptive behavior disorders
Gahan J Pandina, Robert Bilder, Philip D Harvey, et al.
CNS Spectrums
|
March 6, 2004
Impact of recent findings on study design of future autism clinical trials
Eric Hollander, Ann Phillips, Bryan H King, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 3, 2009
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
Ronald N Marcus, Randall Owen, Lisa Kamen, et al.
International Clinical Psychopharmacology
|
August 13, 2005
Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials
John C LeBlanc, Carin E Binder, Jorge L Armenteros, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 28, 2006
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial
L Eugene Arnold, Michael G Aman, Amelia M Cook, et al.
Clinical Therapeutics
|
September 11, 2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders
Michael G Aman, Alexander A Vinks, Bart Remmerie, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 15, 2009
Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder
Jaswinder K Ghuman, Michael G Aman, Harinder S Ghuman, et al.
Journal of Autism and Developmental Disorders
|
January 30, 2021
Executive Function in Autism: Association with ADHD and ASD Symptoms
Rachel R Lee, Anthony R Ward, David M Lane, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
Journal of Autism and Developmental Disorders
|
April 13, 2024
Applicability and Psychometric Properties of General Mental Health Assessment Tools in Autistic People: A Systematic Review
Marianne Berg Halvorsen, Arvid Nikolai Kildahl, Sabine Kaiser, et al.
Research in Developmental Disabilities
|
September 5, 2008
Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children
Michael G Aman, Jill A Hollway, Sarah Leone, et al.
Biological Psychiatry
|
January 11, 2007
Risperidone and cognitive function in children with disruptive behavior disorders
Gahan J Pandina, Robert Bilder, Philip D Harvey, et al.
CNS Spectrums
|
March 6, 2004
Impact of recent findings on study design of future autism clinical trials
Eric Hollander, Ann Phillips, Bryan H King, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 3, 2009
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder
Ronald N Marcus, Randall Owen, Lisa Kamen, et al.
International Clinical Psychopharmacology
|
August 13, 2005
Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials
John C LeBlanc, Carin E Binder, Jorge L Armenteros, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 28, 2006
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial
L Eugene Arnold, Michael G Aman, Amelia M Cook, et al.
Clinical Therapeutics
|
September 11, 2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders
Michael G Aman, Alexander A Vinks, Bart Remmerie, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 15, 2009
Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder
Jaswinder K Ghuman, Michael G Aman, Harinder S Ghuman, et al.
Journal of Autism and Developmental Disorders
|
January 30, 2021
Executive Function in Autism: Association with ADHD and ASD Symptoms
Rachel R Lee, Anthony R Ward, David M Lane, et al.
Page
of 14